Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.
about
Invariant NKT cells as novel targets for immunotherapy in solid tumorsThe role of NKT cells in tumor immunityHow do natural killer T cells help B cells?Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritisSustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer.Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsDoes an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and functionThe functions of type I and type II natural killer T cells in inflammatory bowel diseasesThe regulatory role of invariant NKT cells in tumor immunityA New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor via Systemic Administration by Taking Advantages of the Limitation of EPR EffectEBV promotes human CD8 NKT cell developmentActivation of invariant NKT cells exacerbates experimental visceral leishmaniasisGalactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis.Intravital imaging - dynamic insights into natural killer T cell biologySelf/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?Production of α-galactosylceramide by a prominent member of the human gut microbiotaAdenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cellsInvariant NKT Cell Activation Induces Late Preterm Birth That Is Attenuated by Rosiglitazone.Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergyDefective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.Lymphocytes in cancer development: polarization towards pro-tumor immunityReciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion.The stimulating adventure of KRN 7000.Alpha-galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant NKT-cell activationGlycolipid antigen induces long-term natural killer T cell anergy in mice.Cytokine dependent and independent iNKT cell activationSpleen-resident CD4+ and CD4- CD8α- dendritic cell subsets differ in their ability to prime invariant natural killer T lymphocytes.Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responsesKLRG+ invariant natural killer T cells are long-lived effectors.NKT cells in sepsis.Thymic and peripheral microenvironments differentially mediate development and maturation of iNKT cells by IL-15 transpresentation.Activated iNKT cells promote memory CD8+ T cell differentiation during viral infectionDesigning vaccines based on biology of human dendritic cell subsetsThe clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells.
P2860
Q21284987-517CA1C2-C783-4585-8362-16F8BDE4340AQ24648939-32ACA33B-B629-4108-B76F-E1077B52B68DQ24650966-6F3E467B-F2D8-47FF-96BA-4BD586854226Q24816601-4F837340-E761-4D91-8F04-EDE7F08C5C7DQ25255724-3A1B3E99-180D-4DB5-B413-49AAA7B3F59DQ25256900-CA8E6659-6F82-4B88-9165-DA6AA9029F35Q26748456-0AE2E000-3249-4B09-9807-6C060096EABEQ26768699-B34CE21A-4476-4152-9C3B-C31BC5055C93Q26830239-EDAFE815-AB9C-49BA-9D34-B7F19F1D1D45Q26865391-3BC0E3E7-FFB1-40D8-B813-19306357F67EQ27023425-34EA587A-FDB8-4C0D-95C7-70D083D60E38Q27300754-BD329D4B-556C-42F1-8AD7-B33C1F6494EEQ27314724-40A979DF-C2BB-43F9-83A4-E2DCBAEA3F15Q27318814-5E36F2D3-4CCE-47FE-BC3E-49C4226F5E84Q27667759-3ADDA2F1-3586-44F0-B636-72BAFD12E1E7Q28081530-2F8FD0A8-5019-476C-A2C4-D90B247357BEQ28287583-7B6E0C9E-0FE5-4AB0-A292-3AF07DCABA30Q28534671-1BC8C699-0649-47BF-9BC0-53B985977A48Q30442067-686CE8D8-4D20-4550-B5CD-2368B65E70E7Q30488777-B0E58294-1433-4FA5-B0EB-43EB9DAD879DQ30700375-DB651466-F06E-4272-AB17-9CD8A4E4A937Q33506611-765B0421-DA9A-4ACD-BD9E-41BFA6E84A7EQ33622444-5CDA3AAF-F95C-41C1-838C-B982C1910479Q33712435-676A00BD-93B0-41D6-9112-772D589BEADEQ33720359-6022EE77-4F57-49E8-9BC0-A47EA2829FFBQ33733648-F80F8075-B111-431E-B5ED-1AFD70525CBBQ33753894-7090A80D-EDFA-4595-9FE7-1E679FBFDA3AQ33762686-EFEBB694-8DE2-4C1C-B6F9-233D96B8AEE1Q33843406-87B34169-3F9C-4602-834E-B7194F9F2759Q33877217-9C480BEE-B7DB-4544-9FE6-CA9C719252ADQ33930869-6E5CF25D-FEFD-4362-920E-DC29AB6929FAQ34039891-A8776AE4-C362-425F-8F2E-833189B411EFQ34069630-01B96E0A-73E8-4E77-B414-043AB1D5A953Q34111836-5FDA8969-103C-4E7D-992E-9860D75A653DQ34120251-FD602F6F-BEC4-41B4-85C5-AAA242AEECF0Q34189487-CAA03275-749F-4D1E-B77B-D1A920580221Q34193542-6E7F5558-5D34-4699-9DEC-A5C9F4E9B8F0Q34287659-C1644227-9A00-4C34-9B4F-DC1E85C5B780Q34289152-E0FBB981-9EBA-422C-9AB5-DD20AD74ACDEQ34328138-B5FBCD17-60CD-4070-8C5A-451570894292
P2860
Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Prolonged IFN-gamma-producing ...... galactosylceramide-loaded DCs.
@en
Prolonged IFN-gamma-producing ...... galactosylceramide-loaded DCs.
@nl
type
label
Prolonged IFN-gamma-producing ...... galactosylceramide-loaded DCs.
@en
Prolonged IFN-gamma-producing ...... galactosylceramide-loaded DCs.
@nl
prefLabel
Prolonged IFN-gamma-producing ...... galactosylceramide-loaded DCs.
@en
Prolonged IFN-gamma-producing ...... galactosylceramide-loaded DCs.
@nl
P2093
P2860
P356
P1433
P1476
Prolonged IFN-gamma-producing ...... galactosylceramide-loaded DCs.
@en
P2093
Kanako Shimizu
Ralph M Steinman
Shin-ichiro Fujii
P2860
P304
P356
10.1038/NI827
P407
P577
2002-08-05T00:00:00Z